Latest news – Page 2528

  • News

    Night porter shifts up with a £250,000 book deal

    2000-11-30T00:00:00Z

    A hospital night porter who took 10 years to write a book during quiet shifts has just signed a £250,000 publishing deal.

  • News

    When coughing up is essential

    2000-11-30T00:00:00Z

    GPs are under constant pressure from health authorities to reduce prescribing costs, and nowhere is this more obvious than in the treatment of asthma.

  • News

    Type-righting lessons

    2000-11-30T00:00:00Z

    The huge rise in the type-2 diabetes population - and the introduction of major new drug treatments - is set to pose some increasingly tough management decisions, writes Jenny Bryan

  • News

    Fresh insights into type 2 diabetes

    2000-11-30T00:00:00Z

    Type-2 diabetes used to be called non-insulin-dependent diabetes mellitus because, at least in the early stages of the disease, people do not require insulin treatment.

  • News

    The new drugs and how they work

    2000-11-30T00:00:00Z

    Until recently, the question of which comes first in type-2 diabetes - loss of pancreatic function or development of insulin resistance - was only of academic importance, since there was no effective treatment for insulin resistance.

  • News

    Breathlessness a key sign of COPD

    2000-11-30T00:00:00Z

    The biggest-ever survey among chronic obstructive pulmonary disease (COPD) patients has revealed the enormous detrimental impact COPD has on patients' quality of life and the significant burden the disease places on healthcare services.

  • News

    H pylori drug cash claim

    2000-11-30T00:00:00Z

    Drug treatment to eradicate Helicobacter pylori in infected patients with non-ulcer dyspepsia may be cost-effective, according to a new meta-analysis by the dyspepsia review group (BMJ, 16 September 2000, p659).

  • News

    Channel blockers 'inferior'

    2000-11-30T00:00:00Z

    Calcium channel blockers are inferior to less expensive antihypertensives in preventing cardiovascular complications of high blood pressure, according to a review by US researchers.

  • News

    In Brief

    2000-11-30T00:00:00Z

    An agent that improves survival in metastatic breast cancer patients has been launched. Herceptin (trastuzumab), a humanised monoclonal antibody, suppresses tumour growth in the 20-30 per cent of metastatic breast cancer patients who overproduce a growth factor called HER2. It binds HER2 receptors on the cancer cell surface so that ...

  • News

    Keeping abreast

    2000-11-30T00:00:00Z

    The NHS cancer plan gives the UK nine years to match the best breast cancer survival levels in Europe. As Wendy Moore reports, we could just do it

  • News

    Bring on the clones

    2000-11-30T00:00:00Z

    Once thought of as beyond the pale, the cloning of human embryos is now being encouraged by the government. Jenny Bryan looks at what's in store

  • News

    A cure for Parkinson's disease, multiple sclerosis and strokes?

    2000-11-30T00:00:00Z

    Foetal and embryonic cells have already been used to try to repair nerve damage in people with Parkinson's disease, multiple sclerosis or following a stroke. In the 1980s British doctors were among the first to transplant foetal tissue into the brains of people with Parkinson's disease in an effort to ...

  • News

    Seeing double: what is cloning?

    2000-11-30T00:00:00Z

    Cloning is making genetically identical copies of living things. Scientists have been doing it since the early 1970s with antibodies, cells and genes but, until Dolly's birth, whole-animal cloning proved elusive.

  • News

    It's a bug's life

    2000-11-30T00:00:00Z

    Antimicrobial resistance to antibiotics is a growing problem. But while more research is needed, new data suggests that hospitals might need to change their strategies for dealing with the problem. Rhonda Siddall reports

  • News

    Bucking the trend: new data on antimicrobial resistance

    2000-11-30T00:00:00Z

    The MYSTIC surveillance programme collects data from centres throughout the world that use the antibiotic meropenem, to compare the antibiotic susceptibility of bacterial isolates in specialist and general units year on year.

  • News

    CHC seeks probe into chair job

    2000-11-23T00:00:00Z

    A community health council has called on the commissioner for public appointments to investigate the appointment of a trust chair after a major merger.

  • News

    Reeves to quit NHS on a fiscal high note

    2000-11-23T00:00:00Z

    NHS director of finance and performance management Colin Reeves is to leave the service after 16 years, seven of which were on its top board. His departure in spring 2001 will follow a shake-up of the NHS Executive's finance function.

  • News

    A 'almost impossible' act to follow

    2000-11-23T00:00:00Z

    Trust finance directors who could make the shortlist include Helen Chalmers, Neil Chapman, from Leeds Teaching Hospitals trust, and Barry Elliott, HFMA president, from Barts and the London trust. John Flook, from County Durham and Darlington health authority, was also named along with Bob Dredge, former HFMA chair and director ...

  • News

    NHS money eases Hackney cash woe

    2000-11-23T00:00:00Z

    The NHS has bailed out crisisstricken Hackney council in East London, where a total spending freeze left elderly people 'stuck' in hospital without social services care packages.

  • News

    Trust battles £2.7m overspend

    2000-11-23T00:00:00Z

    King's College Healthcare trust is facing a £2.7m overspend half way through the financial year.